Crossmark Global Holdings’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-14,540
Closed -$131K 1622
2018
Q2
$131K Sell
14,540
-230
-2% -$2.06K ﹤0.01% 1563
2018
Q1
$135K Sell
14,770
-3,693
-20% -$34.2K ﹤0.01% 1545
2017
Q4
$179K Sell
18,463
-12,153
-40% -$90.4K ﹤0.01% 1603
2017
Q3
$208K Buy
+30,616
New +$261K 0.01% 1539
2016
Q3
$208K Buy
+30,616
New +$340K 0.01% 1539

Crossmark Global Holdings's KND Position: Q3 2018 in Review

Crossmark Global Holdings sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 14,540 shares — an estimated $131K sold.

Crossmark Global Holdings first reported a position in KND in Q3 2016 and held it in 5 quarters. The position peaked at $208K in Q3 2017. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Crossmark Global Holdings reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Crossmark Global Holdings sold 14,540 Kindred Healthcare shares in Q3 2018, an estimated $131K.
  • Crossmark Global Holdings first reported a position in Kindred Healthcare in Q3 2016 and held it in 5 quarters.
  • Crossmark Global Holdings's Kindred Healthcare position peaked at $208K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Crossmark Global Holdings's 13F filing for Q3 2018, filed 6 Nov 2018.